药学学报, 2018, 53(9): 1504-1510
引用本文:
王翠宝, 李莹, 卢华辉, 魏南服, 黄硕, 王韵, 饶荣, 许淑珍, 任桐. Z-十八碳-9-烯-丙磺酰胺对糖尿病认知功能障碍小鼠学习记忆功能的影响[J]. 药学学报, 2018, 53(9): 1504-1510.
WANG Cui-bao, LI Ying, LU Hua-hui, WEI Nan-fu, HUANG Shuo, WANG Yun, RAO Rong, XU Shu-zhen, REN Tong. Effects of Z-9-octadecenyl-2-propanesulfonamide on the learning and memory function of diabetes-associated cognitive decline[J]. Acta Pharmaceutica Sinica, 2018, 53(9): 1504-1510.

Z-十八碳-9-烯-丙磺酰胺对糖尿病认知功能障碍小鼠学习记忆功能的影响
王翠宝1, 李莹2, 卢华辉1, 魏南服1, 黄硕1, 王韵1, 饶荣1, 许淑珍1, 任桐3
1. 厦门市第五医院麻醉科, 福建 厦门 361000;
2. 厦门医学院药学系, 福建 厦门 361023;
3. 厦门大学医学院, 福建 厦门 361105
摘要:
探索新化合物Z-十八碳-9-烯-丙磺酰胺(N15)对糖尿病认知功能障碍(DACD)小鼠学习记忆功能的作用及机制。采用链脲佐菌素(STZ)连续小剂量腹腔注射以及高脂高糖加STZ诱导2型糖尿病小鼠模型,N15(50和100 mg·kg-1·d-1)连续灌胃给药6周,于给药末期进行跳台、避暗以及Morris水迷宫测试以评价小鼠学习记忆功能;对海马内葡萄糖和乳酸水平进行测定;通过real time PCR测定海马内突触成长相关蛋白-43(GAP-43)、突触素(SYN)、脑源性生长因子(BDNF)和神经营养因子-3(NT-3) mRNA的表达。结果表明,N15可显著改善模型小鼠学习记忆能力,降低海马内葡萄糖和乳酸含量,显著上调海马内GAP-43、SYN、BDNF和NT-3 mRNA表达水平。上述结果表明,新型化合物N15具有改善糖尿病认知功能障碍的作用,其机制可能与增加海马内突触生长相关因子和神经营养因子表达相关。
关键词:    Z-十八碳-9-烯-丙磺酰胺      糖尿病认知功能障碍      海马      神经保护     
Effects of Z-9-octadecenyl-2-propanesulfonamide on the learning and memory function of diabetes-associated cognitive decline
WANG Cui-bao1, LI Ying2, LU Hua-hui1, WEI Nan-fu1, HUANG Shuo1, WANG Yun1, RAO Rong1, XU Shu-zhen1, REN Tong3
1. Department of Anesthesiology, Xiamen Fifth Hospital, Xiamen 361000, China;
2. Department of Pharmacy, Xiamen Medical College, Xiamen 361023, China;
3. Medical College, Xiamen University, Xiamen 361105, China
Abstract:
This study was designed to investigate the therapeutic effect of novel compound Z-9-octadecenyl-2-propanesulfonamide (N15) on diabetes-associated cognitive decline (DACD). Type 2 diabetes (T2DM) mice models were established with multiple injection of low doses of streptozotocin (STZ) in mice on high fat diet (HFD). Vehicle and different concentrations of N15 (50 and 100 mg·kg-1·d-1) were administrated orally for 6 weeks. The step-down test, dark avoidance task and Morris water maze were conducted at the 6th week. The level of glucose and lactic acid in hippocampus were determined and mRNA of growth associated protein-43 (GAP-43), synaptophysin (SYN), brain derived neurotrophic factor (BDNF) and neurotrophins-3 (NT-3) in hippocampus were analyzed by real time PCR. The beneficial effects of N15 on learning and memory were found in the test of step-down, dark avoidance and Morris water maze. N15 reduced the level of glucose and lactic acid in hippocampus of HFD+STZ-induced diabetic encephalopathy model mice. Additionally, the mRNA expression of GAP-43, SYN, BDNF and NT-3 in hippocampus of HFD+STZ-induced diabetic encephalopathy mice were significantly increased by N15 (P<0.01). These results suggest that the novel compound N15 can ameliorate diabetes-associated cognitive decline and the potential mechanism may be associated with the expressions of increased synaptic-related factors and neurotrophic factor in the hippocampus of diabetesassociated cognitive decline in mice.
Key words:    Z-9-octadecenyl-2-propanesulfonamide    diabetic encephalopathy    hippocampus    neuroprotection   
收稿日期: 2018-04-13
DOI: 10.16438/j.0513-4870.2018-0344
基金项目: 福建省教育厅资助项目(JAT160583).
通讯作者: 李莹,Tel:86-592-2188676,E-mail:renrentt615516@163.com;任桐,Tel:86-592-2103085,E-mail:yinnlee@163.com
Email: renrentt615516@163.com;yinnlee@163.com
相关功能
PDF(352KB) Free
打印本文
0
作者相关文章
王翠宝  在本刊中的所有文章
李莹  在本刊中的所有文章
卢华辉  在本刊中的所有文章
魏南服  在本刊中的所有文章
黄硕  在本刊中的所有文章
王韵  在本刊中的所有文章
饶荣  在本刊中的所有文章
许淑珍  在本刊中的所有文章
任桐  在本刊中的所有文章

参考文献:
[1] Bogush M, Heldt NA, Persidsky Y. Blood brain barrier injury in diabetes:unrecognized effects on brain and cognition[J]. J Neuroimmune Pharmacol, 2017, 12:593-601.
[2] Duarte AI, Santos MS, Oliveira CR, et al. Brain insulin signalling, glucose metabolism and females' reproductive aging:a dangerous triad in Alzheimer's disease[J]. Neuropharmacology, 2018. DOI:10.1016/j.neuropharm.2018.01.044.
[3] Bennett AC, Van Camp A, Lopez V, et al. Sceletium tortuosum may delay chronic disease progression via alkaloid-dependent antioxidant or anti-inflammatory action[J]. J Physiol Biochem, 2018. DOI:10.1007/s13105-018-0620-6.
[4] Ren T, Yang WS, Lin Y, et al. A novel PPAR α/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro[J]. Eur J Pharmacol, 2018, 826:1-8.
[5] Sihag J, Jones PJH. Oleoylethanolamide:the role of a bioactive lipid amide in modulating eating behaviour[J]. Obes Rev, 2018, 19:178-197.
[6] Yang LC, Guo H, Zhou H, et al. Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia[J]. Biochem Pharmacol, 2015, 94:270-281.
[7] Li Y, Xu L, Zeng K, et al. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARalpha/gamma dual agonist, protects against ischemia-induced brain damage in mice by inhibiting inflammatory responses[J]. Brain Behav Immun, 2017, 66:289-301.
[8] Zhao Y, Yan L, Luo XM, et al. A novel PPARalpha agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflamemation in THP-1 cells[J]. Eur J Pharmacol, 2016, 788:104-112.
[9] Zhou X, Zhang F, Hu X, et al. Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice[J]. Physiol Behav, 2015, 151:412-420.
[10] Bartsch T, Dohring J, Reuter S, et al. Selective neuronal vulnerability of human hippocampal CA1 neurons:lesion evolution, temporal course, and pattern of hippocampal damage in diffusion-weighted MR imaging[J]. J Cereb Blood Flow Metab, 2015, 35:1836-1845.
[11] Paul KC, Jerrett M, Ritz B. Type 2 diabetes mellitus and Alzheimer's disease:overlapping biologic mechanisms and environmental risk factors[J]. Curr Environ Health Rep, 2018, 5:44-58.
[12] Gonzalez-Reyes RE, Aliev G, Avila-Rodrigues M, et al. Alterations in glucose metabolism on cognition:a possible link between diabetes and dementia[J]. Curr Pharm Des, 2016, 22:812-818.
[13] Prasad S, Sajja RK, Naik P, et al. Diabetes mellitus and blood-brain barrier dysfunction:an overview[J]. J Pharmacovigil, 2014, 2:125.
[14] Rogers NH, Walsh H, Alvarez-Garcia O, et al. Metabolic benefit of chronic caloric restriction and activation of hypothalamic AGRP/NPY neurons in male mice is independent of ghrelin[J]. Endocrinology, 2016, 157:1430-1442.
[15] Bahmani F, Bathaie SZ, Aldavood SJ, et al. Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats[J]. Mol Vis, 2012, 18:439-448.
[16] Endo M. Effects of vanadate on glucose metabolism of the streptozotocin-diabetic rat lens[J]. Nippon Ganka Gakkai Zasshi, 1993, 97:333-339.
[17] Pintana H, Apaijai N, Kerdphoo S, et al. Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats[J]. Neurosci Lett, 2017, 655:41-45.
[18] Sciacca MFM, Tempra C, Scollo F, et al. Amyloid growth and membrane damage:current themes and emerging perspectives from theory and experiments on Abeta and hIAPP[J]. Biochim Biophys Acta, 2018. DOI:10.1016/j.bbamem.2018. 02.022.
[19] Tucker LB, Velosky AG, McCabe JT. Applications of the Morris water maze in translational traumatic brain injury research[J]. Neurosci Biobehav Rev, 2018, 88:187-200.
[20] Brandewiede J, Schachner M, Morellini F. Ethological analysis of the senescence-accelerated P/8 mouse[J]. Behav Brain Res, 2005, 158:109-121.
[21] Kandimalla R, Manczak M, Fry D, et al. Reduced dynaminrelated protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease[J]. Human Mol Genet, 2016, 25:4881-4897.
[22] Long ZM, Zhao L, Jiang R, et al. Valproic acid modifies synaptic structure and accelerates neurite outgrowth via the glycogen synthase kinase-3beta signaling pathway in an Alzheimer's disease model[J]. CNS Neurosci Ther, 2015, 21:887-897.
[23] Levesque L, Annaert W, Craessaerts K, et al. Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice:evidence for novel speciesspecific properties of human presenilin-1[J]. Mol Med, 1999, 5:542-554.
[24] Abdelwahed OM, Tork OM, Gamal El Din MM, et al. Effect of glucagon-like peptide-1 analogue; exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain visfatin[J]. Brain Res Bull, 2018, 139:67-80.
[25] Tian X, Liu Y, Ren G, et al. Resveratrol limits diabetesassociated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity[J]. Brain Res, 2016, 1650:1-9.